These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9924055)

  • 41. Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists.
    Brown B; Egger S; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    J Med Imaging Radiat Oncol; 2016 Dec; 60(6):744-755. PubMed ID: 27346844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Albertsen PC; Albertsen PC
    J Urol; 2001 Feb; 165(2):731-2. PubMed ID: 11233050
    [No Abstract]   [Full Text] [Related]  

  • 43. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
    van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
    BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate-specific antigen self-testing among British Association of Urological Surgeons (BAUS) consultant urologists.
    Davis NF; McGuire BB; Flood HD
    Urology; 2010 Oct; 76(4):1023-4. PubMed ID: 20932429
    [No Abstract]   [Full Text] [Related]  

  • 45. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rates of self-reported 'burnout' and causative factors amongst urologists in Ireland and the UK: a comparative cross-sectional study.
    O'Kelly F; Manecksha RP; Quinlan DM; Reid A; Joyce A; O'Flynn K; Speakman M; Thornhill JA
    BJU Int; 2016 Feb; 117(2):363-72. PubMed ID: 26178315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer".
    Barry MJ
    Arch Intern Med; 2010 Mar; 170(5):450-2. PubMed ID: 20212181
    [No Abstract]   [Full Text] [Related]  

  • 49. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan.
    Noguchi M; Matsuoka K; Koga H; Kanetake H; Nakagawa M; Naito S
    Int J Clin Oncol; 2006 Oct; 11(5):390-5. PubMed ID: 17058137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of cancers of the head and neck in the United Kingdom: questionnaire survey of consultants.
    Edwards D; Johnson NW; Cooper D; Warnakulasuriya KA
    BMJ; 1997 Dec; 315(7122):1589. PubMed ID: 9437278
    [No Abstract]   [Full Text] [Related]  

  • 53. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer".
    Matsumoto R
    Int J Urol; 2023 Mar; 30(3):297. PubMed ID: 36541073
    [No Abstract]   [Full Text] [Related]  

  • 55. Editorial Comment on a national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer.
    Kishida T
    Int J Urol; 2023 Mar; 30(3):298. PubMed ID: 36653112
    [No Abstract]   [Full Text] [Related]  

  • 56. The trend of managing prostate cancer in Taiwan.
    Wong WY; Chen SC; Chueh SC; Chen J
    Int J Urol; 2004 Jul; 11(7):510-4. PubMed ID: 15242360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
    Protopapa E; van der Meulen J; Moore CM; Smith SC
    BJU Int; 2017 Oct; 120(4):468-481. PubMed ID: 28437031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the French practices in brachytherapy using surveys].
    Delattre B; Cormier L; Borgogno C; Descotes JL; Peiffert D; Hannoun-Levi JM; Moreau JL
    Prog Urol; 2017 Oct; 27(12):626-631. PubMed ID: 28651992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Written information material and availability of sexual health care for men experiencing sexual dysfunction after prostate cancer treatment: An evaluation of Dutch urology and radiotherapy departments.
    Grondhuis Palacios LA; Krouwel EM; Duijn M; den Oudsten BL; den Ouden ME; Putter H; Pelger RC; Elzevier HW
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28026069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.